Non-Invasive Cardiac and Vascular Monitoring in Systemic Sclerosis
Author Information
Author(s): Magda Ștefania Lucia, Gheorghiu Ana Maria, Mincu Raluca Ileana, Ciobanu Andrea Olivia, Constantinescu Tudor, Popa Elisa Cristina, Mihai Carina, Vinereanu Dragoș
Primary Institution: Department of Cardiology and Cardiovascular Surgery, “Carol Davila” University of Medicine and Pharmacy, Bucharest, Romania
Hypothesis
SSc causes microvascular damage and myocardial fibrosis, leading to permanent cardiac and vascular dysfunction over time.
Conclusion
Subclinical cardiac dysfunction in SSc can be detected early using advanced echocardiographic techniques, and standard therapies may prevent disease progression in the short to medium term.
Supporting Evidence
- SSc patients showed significantly altered 4D echocardiography parameters compared to controls.
- Standard echocardiography parameters were normal at baseline in SSc patients.
- After 1 and 2 years of treatment, no significant changes in cardiac function were observed.
Takeaway
People with systemic sclerosis can have heart problems that aren't obvious at first, but special tests can find them early, and treatment can help keep their hearts healthy.
Methodology
The study included 60 SSc patients and 30 matched controls, using 2D and 4D echocardiography to assess heart function and arterial stiffness over 1 and 2 years.
Potential Biases
Potential bias due to the exclusion of patients with overt cardiovascular disease and the heterogeneity of treatment regimens.
Limitations
The study cohort is small and from a single center, which may limit generalizability.
Participant Demographics
The study included 60 subjects, predominantly female (58), with a mean age of 54 years.
Statistical Information
P-Value
p ≤ 0.02
Statistical Significance
p ≤ 0.02
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website